Total Payments
$564.09
2022 Payments
$13.89
Companies
6
Transactions
12
Medicare Patients
8,263
Medicare Billing
$790,625
Payment Breakdown by Category
Food & Beverage$550.20 (97.5%)
Education$13.89 (2.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $550.20 | 11 | 97.5% |
| Education | $13.89 | 1 | 2.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $142.66 | 4 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $121.89 | 1 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $108.62 | 1 | $0 (2017) |
| E.R. Squibb & Sons, L.L.C. | $92.89 | 1 | $0 (2017) |
| Amarin Pharma Inc. | $68.86 | 3 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $29.17 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $13.89 | 1 | AstraZeneca Pharmaceuticals LP ($13.89) |
| 2021 | $113.02 | 5 | Amarin Pharma Inc. ($68.86) |
| 2020 | $25.86 | 1 | Janssen Pharmaceuticals, Inc ($25.86) |
| 2019 | $72.64 | 1 | Janssen Pharmaceuticals, Inc ($72.64) |
| 2017 | $338.68 | 4 | Boehringer Ingelheim Pharmaceuticals, Inc. ($121.89) |
All Payment Transactions
12 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/06/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Education | In-kind items and services | $13.89 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/09/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: Cardiovascular | ||||||
| 08/26/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/21/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $23.64 | General |
| Category: Cardiovascular | ||||||
| 06/24/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $25.78 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/09/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $23.24 | General |
| Category: Cardiovascular | ||||||
| 09/03/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $25.86 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/25/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $72.64 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/25/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $92.89 | General |
| Category: Cardiovascular | ||||||
| 10/05/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $121.89 | General |
| Category: DIABETES | ||||||
| 07/06/2017 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/23/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $108.62 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,655 | 2,203 | $482,150 | $135,894 |
| 2022 | 14 | 1,856 | 2,554 | $464,635 | $143,929 |
| 2021 | 18 | 2,282 | 3,080 | $717,650 | $224,334 |
| 2020 | 16 | 2,470 | 3,718 | $866,545 | $286,469 |
Total Patients
8,263
Total Services
11,555
Medicare Billing
$790,625
Procedure Codes
65
All Medicare Procedures & Services
65 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 216 | 410 | $92,250 | $41,364 | 44.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 140 | 150 | $141,750 | $25,008 | 17.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 202 | 310 | $62,000 | $21,915 | 35.3% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 117 | 123 | $47,970 | $19,266 | 40.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 56 | 56 | $17,080 | $7,031 | 41.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 126 | 126 | $44,100 | $6,478 | 14.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 268 | 408 | $30,600 | $4,755 | 15.5% |
| 93978 | Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | Office | 2023 | 24 | 24 | $10,080 | $3,504 | 34.8% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 419 | 507 | $25,350 | $3,320 | 13.1% |
| 93923 | Complete ultrasound study of arm and leg arteries | Office | 2023 | 21 | 21 | $7,350 | $2,342 | 31.9% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 20 | 21 | $1,575 | $406.80 | 25.8% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 13 | 13 | $975.00 | $249.99 | 25.6% |
| 93242 | Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 13 | 13 | $650.00 | $136.89 | 21.1% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2023 | 20 | 21 | $420.00 | $117.20 | 27.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 239 | 497 | $106,805 | $51,635 | 48.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 210 | 325 | $61,030 | $22,915 | 37.5% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2022 | 128 | 138 | $53,820 | $22,390 | 41.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 97 | 98 | $92,610 | $16,843 | 18.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 133 | 140 | $49,000 | $7,822 | 16.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 39 | 39 | $11,670 | $5,313 | 45.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 282 | 433 | $32,475 | $5,132 | 15.8% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 612 | 756 | $37,800 | $4,964 | 13.1% |
| 93978 | Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | Office | 2022 | 17 | 17 | $7,140 | $2,738 | 38.3% |
| 93923 | Complete ultrasound study of arm and leg arteries | Office | 2022 | 17 | 17 | $5,950 | $1,938 | 32.6% |
| 93280 | Programming of dual lead pacemaker system | Office | 2022 | 12 | 16 | $2,000 | $1,085 | 54.2% |
About Dr. Sun Wan, MD
Dr. Sun Wan, MD is a Cardiovascular Disease healthcare provider based in Manchester, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1043290281.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sun Wan, MD has received a total of $564.09 in payments from pharmaceutical and medical device companies, with $13.89 received in 2022. These payments were reported across 12 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($550.20).
As a Medicare-enrolled provider, Wan has provided services to 8,263 Medicare beneficiaries, totaling 11,555 services with total Medicare billing of $790,625. Data is available for 4 years (2020–2023), covering 65 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Manchester, CT
- Active Since 01/21/2006
- Last Updated 08/02/2013
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1043290281
Products in Payments
- XARELTO (Drug) $142.66
- JARDIANCE (Drug) $121.89
- ENTRESTO (Drug) $108.62
- ELIQUIS (Drug) $92.89
- Vascepa (Drug) $68.86
- BRILINTA (Drug) $15.28
- FARXIGA (Drug) $13.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Manchester
Dr. Fahad Gilani, M.d, M.D
Cardiovascular Disease — Payments: $389,229
Cardiovascular Disease $389,229
Dr. Robert Capodilupo, M.d, M.D
Cardiovascular Disease — Payments: $180,535
Cardiovascular Disease $180,535
Dr. Stephan Heo, M.d, M.D
Cardiovascular Disease — Payments: $97,578
Cardiovascular Disease $97,578
Jeanney Lew, M.d, M.D
Cardiovascular Disease — Payments: $18,141
Cardiovascular Disease $18,141
Dr. Jinu John, M.d, M.D
Cardiovascular Disease — Payments: $15,879
Cardiovascular Disease $15,879
Mr. Venkateswara Narla, Md, MD
Cardiovascular Disease — Payments: $9,752
Cardiovascular Disease $9,752